Liverpool, United Kingdom

Patricia Rutherford

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Ucl Business Plc, Vitaflo International Ltd, Vitaflow (International) Ltd. Active years: 2022-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Patricia Rutherford: Innovator in Dietary Therapies

Introduction

Patricia Rutherford is a notable inventor based in Liverpool, GB. She has made significant contributions to the field of dietary therapies, particularly in relation to mitochondrial dysfunction and epilepsy. With a total of 3 patents, her work has the potential to impact many lives.

Latest Patents

Rutherford's latest patents include a nutritional product aimed at treating disorders associated with mitochondrial dysfunction, including epilepsy. Additionally, she has developed a composition for use in the treatment of epilepsy, which comprises a decanoic acid to octanoic acid ratio of 70:30 to 90:10 wt/wt. This composition is designed to help control epileptic seizures effectively.

Career Highlights

Throughout her career, Patricia has worked with reputable companies such as UCL Business Plc and Vitaflo International Ltd. Her experience in these organizations has allowed her to refine her expertise in dietary therapies and contribute to innovative solutions in the field.

Collaborations

Some of her notable coworkers include Simon Heales and Simon Eaton. Their collaboration has likely enriched her research and development efforts, leading to advancements in her patented inventions.

Conclusion

Patricia Rutherford's work in dietary therapies showcases her dedication to improving health outcomes for individuals with mitochondrial dysfunction and epilepsy. Her innovative patents reflect her commitment to advancing medical science and providing effective treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…